Author: Steve Kopczak

• Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer.
• Huang TT, Burkett SS, Tandon M, Yamamoto TM, Gupta N, Bitler BG, Lee JM, Nair JR.
• Oncogene. 2022 Oct 12. doi: 10.1038/s41388-022-02491-8. Epub ahead of print.

• PMID: 36224341
• PubMed abstract
• Source abstract

• Genetic Testing Challenges in Oncology: Missed Variant Update Delays Li-Fraumeni Diagnosis.
• Ray T.
• Precision Oncology News. 2022 Oct 12.

• Case report
• Free Full Text

Related:

Special article:

Is there a duty to reinterpret genetic data? The ethical dimensions.

• PMID: 31616070
• PubMed abstract
• Free Full Text

• PARP-inhibition reprograms macrophages toward an anti-tumor phenotype.
• Wang L, Wang D, Sonzogni O, Ke S, Wang Q, Thavamani A, Batalini F, Stopka SA, Regan MS, Vandal S, Tian S, Pinto J, Cyr AM, Bret-Mounet VC, Baquer G, Eikesdal HP, Yuan M, Asara JM, Heng YJ, Bai P, Agar NYR, Wulf GM.
• Cell Rep. 2022 Oct 11;41(2):111462. doi: 10.1016/j.celrep.2022.111462.

• PMID: 36223740
• PubMed abstract

• Free Full Text